Europe Markets for Orthopedic Biomaterials 2015-2021

Jul 21, 2015, 08:43 ET from Research and Markets

DUBLIN, July 14, 2015 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Europe Markets for Orthopedic Biomaterials 2011-2021" report to their offering.

The market for European orthopedic biomaterials (OB) has undergone dramatic changes over the last two years. Prices, quantities sold, and competitors have been in an almost constant state of flux. While quantities sold are marginally increasing, ASPs (average sales prices) are being driven down by an increase in competition.

Included in this analysis are the markets for bone morphogenetic proteins (BMPs), hyaluronic acid viscosupplementation injections, bone graft substitutes, and autologous chondrocyte implantations (ACIs).

While the entire OB market has been in a state of contraction over the past few years, especially following Olympus's exit from the BMP market, it is expected to resume marginal growth in 2015. Of those four segments, the markets for autologous chondrocyte implantations and bone morphogenetic proteins have become monopolies.

The European market for orthopedic materials is segmented into bone graft substitutes (BGS), which includes allograft, synthetic and demineralized bone matrices (DBM); bone morphogenetic protein (BMP) growth factors; hyaluronic acid (HA) viscosupplementation; and autologous chondrocyte implantation (ACI).

The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation injections, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantations (ACI). The HA market experienced significant contractions in 2012 and 2013 due to the extreme price competition resulting from an increase in competition, especially in Germany.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. European Orthopedic Biomaterials Market

4. Country Profiles

5. Bone Graft Substitute Market

6. Hyaluronic Acid Viscosupplementation Market

7. Bone Morphogenetic Protein Growth Factor Therapy Market

8. Autologous Chondrocyte Implantation Market

Companies Mentioned

- Baxter

- Biomet

- Bonalive

- Croma-Pharma

- Depuy Synthes

- Fidia

- Fin-Ceramica

- Laboratoire Genevrier

- Meda Pharma

- Medtronic

- RTI Biologics

- Recordati

- Sanofi

- Seikagaku

- Smith and Nephew

- Sobi

- Stryker

- TRB Chemedica

- Tedec Meiji

- Wright Medical

- Zimmer

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets